1. Kola, I. & Rafferty, M. New technologies that may impact drug discovery in the 5–10 year timeframe workshop. 2002 Biomed. Expo Ann Arbor Michigan (data derived from Prous Science, Drugs News Prospect (2002).
2. Franz, S. 2003 approvals: a year of innovation and upward trends. Nature Rev. Drug Discov. 3, 103–105 (2004).
3. Accenture Consulting. High performance drug discovery: an operating model for a new era. Accenture (2001).
4. DiMasi, J. A., Hansen, R. W. & Grabowski, H. G. The price of innovation: new estimates of drug development costs. J. Health Econ. 22, 151–185 (2003).
5. Fearn, C. J. IMS Health. The World Pharmaceutical Market Presented at the Strategic Management Review, Australia, 19–20 June (2002).